FREE Medical Technologist Trivia Questions and Answers
How many different medical technologies are there today?
In 16 broad areas, including active implantable technology, in vitro diagnostics technology, optical technology, and dental technology, there are more than 500,000 recognized medical technologies.
The 19th century saw the advent of prosthetics.
Prosthetics have been used since roughly 3000 BC. Records indicate that ancient civilizations like the Roman Empire, Persia, and ancient Peru employed prostheses.
Dividing body vertically into right and left
The term you're referring to is the "Midsagittal Plane." This plane divides the body vertically into two equal halves, creating right and left sides. It passes through the midline of the body and is also sometimes called the "median plane." This type of division is particularly useful in anatomical descriptions to study the symmetry and relationships of structures within the body.
In 1924, American scientists invented the first syringe.
Syringes, a widely used medical instrument, were first mentioned in Alexandria in 280 BC. It was mostly used to remove objects from the ear.
Which of the following is not a form of medicine?
Medical technology includes medical tools, in vitro diagnostics, imaging technologies, and e-health solutions to identify, track, evaluate, and treat patients with various illnesses. They can be categorized as any technology utilized to save and enhance people's lives.
More than 500,000 medical technologies are on the market, saving and improving lives daily.
Reproductive organs urinary bladder last section of large intestine and pelvic girdle
The structures you mentioned, including the reproductive organs, urinary bladder, last section of the large intestine (rectum), and the pelvic girdle, are all located within the "pelvic cavity." The pelvic cavity is the lower part of the abdominopelvic cavity and is bounded by the pelvic bones. It contains various important organs and structures related to reproduction, urinary function, and digestion, as well as supporting structures like the pelvic girdle.
How much of Europe's overall healthcare budget is spent on medical technology? This inquiry is necessary.
Only 7.5% of the average 10.4% of GDP spent on healthcare may be attributable to medical technologies.
Away from the point of attachment
"distal" is the term used to describe a location that is farther away from the point of attachment or origin of a structure. It is often used in anatomical descriptions to indicate the relative position of body parts in relation to their attachment points. The opposite term is "proximal," which describes a location that is closer to the point of attachment or origin.
Cell division controlled by the nucleus of cell-
Clotting condition in which the fibrinogen molecule has a defective structural makeup.
Dysfibrinogenemia" is a medical term used to describe a clotting disorder where there is a defect in the structural makeup of the fibrinogen molecule. Fibrinogen is a protein involved in the blood clotting process, and abnormalities in its structure can lead to impaired clot formation and potential bleeding or clotting issues. Dysfibrinogenemia can vary in severity and may be inherited or acquired. It's considered a type of coagulopathy, a disorder that affects the blood's ability to clot properly.
How many patent applications for medical technology were made in Europe in 2014? This inquiry is necessary.
Medical technology is distinguished by a steady stream of developments resulting from intense internal industry research and development and close user collaboration.
In 2014 the medical technology industry registered 11,124 patent applications- 7% of the total number of applications, more than any other European sector. In comparison, 5,300 applications were filled in the pharmaceutical field and 5,900 in the biotechnology field.
Tendency to gain virulence over time. Untreated conditions tend to get worse, leading to serious sickness or death.
"Malignancy" primarily refers to the tendency of certain cancers to grow and spread aggressively. However, based on your description, the term that fits the context you provided is "progressive." A condition or disease that tends to worsen over time, leading to serious consequences if left untreated, is described as "progressive." This term encompasses the idea that the condition advances and becomes more severe as time goes on.
Condition characterized by abrupt kidney failure, low platelet count, and hemolytic anemia.
The term you're referring to is "intestinal microbiota" or "intestinal microbiome." These are the beneficial bacteria and other microorganisms that naturally reside in the human intestines. They play important roles in digestion, nutrient absorption, immune system regulation, and other aspects of overall health. "Fecal flora" is also related to this concept, but it specifically refers to the microbial community found in feces, which is reflective of the microbiota inhabiting the intestines.
Normal or balance state within
Homeostasis is the process by which living organisms maintain a stable internal environment despite external changes. It involves the regulation of various physiological variables, such as temperature, pH, blood pressure, and more, to keep them within a narrow range that is optimal for the body's functioning. The body's ability to achieve and maintain homeostasis is essential for its overall health and proper functioning.
Which of these claims regarding IVDs is untrue?
In vitro diagnostics (IVDs) are non-invasive procedures that assess a person's health by analyzing biological samples (such as blood, urine, or tissues). They never interact with people face-to-face. They give details on a sample taken from an individual. As a result, the caliber of the information they offer determines their value. IVDs do not directly treat patients. They inform patients about their health status rather than directly affecting a patient's condition. To choose a patient's course of treatment, IVDs are used. To determine the best course of therapy and care for patients, healthcare professionals analyze data from IVDs. This implies that accurate decision-making depends on the healthcare professional's proficiency with the IVD. Although more than 40 000 IVD products are available in Europe, just 0.8% of all healthcare spending—or 20,6 euros per person annually—is spent on IVDs.